Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
28.00 SEK | -3.45% | -2.78% | -21.79% |
08-29 | First Patient Dosed in Guard Therapeutics' Phase 2B Study POINTER | CI |
08-27 | Guard Therapeutics Plans New SEK80 Million Rights Issue to Fund Kidney Drug Study | MT |
- Stock Market
- Equities
- GUARD Stock
- Charts Guard Therapeutics International AB
- Total Return chart
MarketScreener is also available in this country: United States.
Switch edition